JM
0
Active Trials
1
Total Trials
0
Organizations
0
Events
Jamaica
Medical Only (Private)
Reimbursed Care Access
Jamaica is widely known for a permissive stance toward psilocybin-containing mushrooms (they are not scheduled under Jamaican law) and hosts commercial retreats and producers. Other classical and synthetic psychedelics (MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X) fall under Jamaica’s general Dangerous Drugs regulatory framework and are treated as controlled/illegal except insofar as they are used in approved clinical research. Ketamine is used in Jamaica as an established anesthetic in healthcare settings and can be prescribed; however, licensed esketamine (Spravato) does not appear to have a public national reimbursement pathway and psychedelic-assisted indications are confined largely to private/clinical‑trial settings.